טוען...
Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D(179)Y Substitution in the KPC-2 β-Lactamase
The ceftazidime-avibactam antibiotic combination was recently shown to be at risk for the emergence of resistance under treatment. To gain insight into the underlying mechanism, we have analyzed the catalytic properties of a Klebsiella pneumoniae carbapenemase type 2 (KPC-2) β-lactamase harboring th...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5487616/ https://ncbi.nlm.nih.gov/pubmed/28461318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00451-17 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|